Securing and developing personnel supporting research and development and manufacturing
First written in FY2023. 1 of 3 entries say "Advanced", first in FY2024. Latest entry: FY2026.
The whole theme swung hardest in 2026: 3 of 34 companies on the "Worse" side.
5 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Using this subsidy, we are working with Nakanoshima Qross (the International Innovation Center for Medical Care, Kita-ku, Osaka) to develop highly skilled personnel for the CDMO business, and plan to recruit and develop new graduates who will support the company’s future.」
The company continued its policy of recruiting and developing personnel for research and development, manufacturing and CDMO, and specifically pursued advanced personnel development and new-graduate recruitment and development with Nakanoshima Qross. Consolidated headcount was 51. - FY2024AdvancedAnnual report
「During the consolidated fiscal year under review, we focused on securing personnel, and the number of employees increased by 28.3% from the end of the previous consolidated fiscal year.」
Focused recruitment increased the number of employees by 28.3% from the end of the previous consolidated fiscal year to 59 as of 31 March 2024. - FY2023First statedAnnual report
「By leveraging our strength in enabling advanced career development based on research and development of next-generation treatment technologies and diverse business plans, we will secure and expand our pool of excellent personnel through employee development and proactive recruitment.」
There were 40 research and development personnel, including temporary employees, accounting for approximately 77% of total employees. Securing personnel and transferring expertise as the organization expands remain challenges.